Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 2
1955 1
1956 3
1957 1
1958 2
1959 3
1960 8
1961 8
1962 9
1963 14
1964 5
1965 1
1966 1
1967 5
1968 4
1969 1
1970 4
1971 2
1975 1
1976 2
1977 1
1978 4
1979 1
1982 1
1983 4
1984 1
1985 1
1987 1
1988 1
1989 2
1991 1
1994 1
1995 2
1996 1
1997 3
1999 1
2000 7
2001 4
2002 5
2003 8
2004 8
2005 15
2006 22
2007 13
2008 4
2009 11
2010 9
2011 11
2012 18
2013 22
2014 32
2015 17
2016 27
2017 37
2018 38
2019 60
2020 46
2021 48
2022 35
2023 39
2024 35
2025 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Schneider B, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Young JS, Yeung K, Dwyer MA, Kumar R. Gradishar WJ, et al. J Natl Compr Canc Netw. 2023 Jun;21(6):594-608. doi: 10.6004/jnccn.2023.0031. J Natl Compr Canc Netw. 2023. PMID: 37308117
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN Jr, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey JC. Singh P, et al. Ann Surg Oncol. 2025 Feb;32(2):899-911. doi: 10.1245/s10434-024-16484-2. Epub 2024 Nov 13. Ann Surg Oncol. 2025. PMID: 39538100
Immunotherapy in Triple-Negative Breast Cancer.
Tiberi E, Parisi A, Pistelli M, Savini A, Galassi F, Reschini C, Quintavalle D, Napoleoni R, Ferrari C, Berardi R. Tiberi E, et al. Oncol Ther. 2025 Sep;13(3):547-575. doi: 10.1007/s40487-025-00346-2. Epub 2025 May 26. Oncol Ther. 2025. PMID: 40418298 Free PMC article. Review.
T-cell-based breast cancer immunotherapy.
Pilipow K, Darwich A, Losurdo A. Pilipow K, et al. Semin Cancer Biol. 2021 Jul;72:90-101. doi: 10.1016/j.semcancer.2020.05.019. Epub 2020 May 31. Semin Cancer Biol. 2021. PMID: 32492452 Review.
ATM mutations for surgeons.
Mansfield SA, Pilarski R, Agnese DM. Mansfield SA, et al. Fam Cancer. 2017 Jul;16(3):407-410. doi: 10.1007/s10689-016-9959-4. Fam Cancer. 2017. PMID: 27988859 Review.
[Porphyria].
CERNICH IR, RODRIGUEZ NIETO A, AGNESE CA. CERNICH IR, et al. Sem Med. 1960 Aug 11;117:519-20. Sem Med. 1960. PMID: 13691985 Spanish. No abstract available.
641 results